Article ; Online: Combined inhibition/silencing of diacylglycerol kinase α and ζ simultaneously and synergistically enhances interleukin-2 production in T cells and induces cell death of melanoma cells.
Journal of cellular biochemistry
2021 Volume 122, Issue 5, Page(s) 494–506
Abstract: ... it promotes the nonresponsive immune state known as T-cell anergy. Moreover, a DGKα-selective inhibitor, CU-3 ... induced cell death in cancer-derived cells and simultaneously enhanced T-cell interleukin-2 production ... In addition to DGKα, DGKζ is also known to induce T-cell anergy. In the present study, we examined ...
Abstract | The α-isozyme of diacylglycerol kinase (DGK) enhances cancer cell proliferation and, conversely, it promotes the nonresponsive immune state known as T-cell anergy. Moreover, a DGKα-selective inhibitor, CU-3, induced cell death in cancer-derived cells and simultaneously enhanced T-cell interleukin-2 production. In addition to DGKα, DGKζ is also known to induce T-cell anergy. In the present study, we examined whether combined inhibition/silencing of DGKα and DGKζ synergistically enhanced T-cell activity. Combined treatment with CU-3 or DGKα-small interfering RNA (siRNA) and DGKζ-siRNA more potently enhanced T-cell receptor-crosslink-dependent interleukin-2 production in Jurkat T cells than treatment with either alone. Intriguingly, in addition to activating T cells, dual inhibition/silencing of DGKα and DGKζ synergistically reduced viability and increased caspase 3/7 activity in AKI melanoma cells. Taken together, these results indicate that combined inhibition/silencing of DGKα and DGKζ simultaneously and synergistically enhances interleukin-2 production in T cells and induces cell death in melanoma. Therefore, dual inhibition/silencing of these DGK isozymes represents an ideal therapy that potently attenuates cancer cell proliferation and simultaneously enhances immune responses that impact anticancer immunity. |
---|---|
MeSH term(s) | Apoptosis/physiology ; Blotting, Western ; Cell Death/physiology ; Cell Line ; Cell Survival/physiology ; Diacylglycerol Kinase/genetics ; Diacylglycerol Kinase/metabolism ; Humans ; Interleukin-2/metabolism ; Jurkat Cells/metabolism ; RNA Interference ; T-Lymphocytes/metabolism |
Chemical Substances | Interleukin-2 ; Diacylglycerol Kinase (EC 2.7.1.107) |
Language | English |
Publishing date | 2021-01-05 |
Publishing country | United States |
Document type | Journal Article |
ZDB-ID | 392402-6 |
ISSN | 1097-4644 ; 0730-2312 |
ISSN (online) | 1097-4644 |
ISSN | 0730-2312 |
DOI | 10.1002/jcb.29876 |
Database | MEDical Literature Analysis and Retrieval System OnLINE |
Full text online
More links
Kategorien
In stock of ZB MED Cologne/Königswinter
Zs.A 1114: Show issues | Location: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular Jg. 1995 - 2021: Lesesall (1.OG) ab Jg. 2022: Lesesaal (EG) |
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.